SYNLOGIC, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
SYNLOGIC, INC. (SYBX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 680.33 thousand shares for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-10.
Discontinued › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2021-11-10
- SYNLOGIC, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2021-09-30 was 332.02K shares.
- SYNLOGIC, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2021-06-30 was 250.32K shares.
- SYNLOGIC, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2021-03-31 was 97.98K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month |
|---|---|---|---|
| 2021-09-30 | 332.02K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | 582.35K shares derived: sum of 2 quarters · filed 2021-11-10 | 680.33K shares 10-Q · filed 2021-11-10 |
| 2021-06-30 | 250.32K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | 348.31K shares 10-Q · filed 2021-08-12 | |
| 2021-03-31 | 97.98K shares 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |